Seeking Alpha

Amgen to acquire Onyx for $125 a share

  • It's official: Amgen (AMGN) will acquire Onyx (ONXX) for $125/ share, putting to rest weeks of speculation about what the terms of the deal would turn out to be after a dispute over Kyprolis data reportedly put the two companies at odds over price.
  • More on the deal here.
Comments (3)
  • Is there going to be more offers?
    25 Aug 2013, 07:01 PM Reply Like
  • Very unlikely.
    25 Aug 2013, 07:35 PM Reply Like
  • Amgen to Acquire Onyx Pharmaceuticals for $125 per share! I hope that Amgen gets its money worth on the Kyprolis drug and other drugs in the pipeline. Whether the 10.4 Billion dollars is worth it remains to be seen!
    26 Aug 2013, 09:23 AM Reply Like
DJIA (DIA) S&P 500 (SPY)